Journals / Turkish Journal of Gastroenterology / 2013 / Cilt: 24 - Sayı: 5

Long-term effectiveness of BioEnterics intragastric balloon in obese patients

Obez hastalarda BioEnterik intragastrik balonların uzun süreli etkinliği

Pages
387–391
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: BioEnterics intragastric balloon has been effective in long-term loss of body weight.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study has been presented at Asian Pasific Digestive Week, 2012, BangkokAddress for correspondence:Ümit Bilge DO/ANAdana Numune Training and Research Hospital, Department of Gastroenterology, Adana, TurkeyE-mail: [email protected] study aimed to evaluate the effect of this method on long-term weight loss.
📊
Key Findings & Data:Material and Methods: From June 2009 to June2011, 32 patients (14 male, 18 female) underwent BioEnterics intragastric balloon therapy for 6 months.
💡
Conclusion & Impact:Conclusion: BioEnterics intragastric balloon has been effective in long-term loss of body weight.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

This study has been presented at Asian Pasific Digestive Week, 2012, BangkokAddress for correspondence:Ümit Bilge DO/ANAdana Numune Training and Research Hospital, Department of Gastroenterology, Adana, TurkeyE-mail: [email protected] study aimed to evaluate the effect of this method on long-term weight loss. Material and Methods: From June 2009 to June2011, 32 patients (14 male, 18 female) underwent BioEnterics intragastric balloon therapy for 6 months. The mean age of the subjects was 39,7±11,1 years and mean body mass index was 44,4±12 kg/m2. All patients were given a diet of 1100 kcal/day. Weightloss parameters [absolute weight loss, body mass index loss, percentage of body weight loss, and percentage of excess body mass indexloss (excess body mass index loss%)] were recorded at baseline, after 1 month, after 6 months (time of BioEnterics intragastric balloon removal), and after 12 months from baseline. Successful weight loss was defined as >=10% weight loss after 6 (end of treatmentsuccess) and 12 months (long-term success). Statistical analysis was done using SPSS computer program. Results: The meanweight loss and body mass index loss were 12,4 kg (standart deviation, 13,5) and 4.3 kg/m2(standart deviation, 4,7), respectively(p<0.001). The mean percentage of body weight loss was 9.5% (standart deviation, 9,8). The percentage of excess body mass indexloss reached 25,2% (standart deviation, 25,9). Fifteen patients (46,9%) achieved a percentage of body weight loss >10% at the end oftreatment. Eleven of these patients (73%) were able to maintain weight loss of 10% at the completion of the study, resulting in a longterm success rate of 34.4%. Percentage of body weight loss and percentage of excess body mass index loss were inversely related toage (p< 0,05). Conclusion: BioEnterics intragastric balloon has been effective in long-term loss of body weight.

Özet

Giriş ve Amaç: Bioenterik intragastrik balonun kilo kaybı için etkili ve invazif olmayan bir metod olduğu düşünülmektedir. Bu metodun kilo kaybı üzerindeki uzun süreli etkisini değerlendirmeyi amaçladık. Gereç ve Yöntem: 2009 Haziran ayından 2011 Ha- ziran ayına kadar 32 hastaya (14 erkek, 18 kadın) 6 ay süreyle BioEnterik İntragastrik balon tedavisi uygulandı. Hastalarda or- talama yaş 39,7±11,1, ortalama vücut kitle indeksi 44,4±12 kg/m2idi. Bütün hastalara 1100 kcal/gün diyet verildi. Kilo kaybı pa- rametreleri (kilo kaybı, vücut kitle indeksi kaybı, vücut kilo kaybı yüzdesi, fazla vücut kitle indeksi kayıp yüzdesi) başlangıçta, 1 ay sonra, 6 ay sonra (Bioenterik intragastrik balon çıkartılma zamanı) ve 12 ay sonra kaydedildi. İstatistiksel analizler SPSS bilgi- sayar programı kullanılarak yapıldı. Bulgular: Ortalama kilo kaybı ve vücut kitle indeksi kaybı sırasıyla 12,4 kg (standart sapma, 13,5) ve 4,3 kg/m2(standart sapma, 4,7) idi (p %10 oldu. Bu hastaların 11 tanesi (%73) çalışma sonunda %10'luk kilo kaybını koruyabildi. Böylece uzun dönem ba- şarı oranı %34,4 oldu. Vücut kilo kaybı ve fazla vücut kitle indeksi kayıp yüzdeleri yaşla ters orantılıydı (p<0.05). Sonuç: BioEn- teric intragastric balon vücut ağırlığının uzun süreli kaybında etkili olmuştur.

🔖

Cite This Article

GÜMÜRDÜLÜ, Y., DOAN, Ü. B., AKIN, M. S., TAŞDOĞAN, B. E., YALAKİ, S. (2013). Long-term effectiveness of BioEnterics intragastric balloon in obese patients. Turkish Journal of Gastroenterology, Cilt: 24 - Sayı: 5, 387–391. https://ajindex.com/articles/410773

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Ustu Y, Ugurlu M, Aslan O, et al. High prevalence of obesity in Tokat, a northern province of Turkey. J Pak Med Assoc 2012; 62:435-40
  2. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25:358-63
  3. O'Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006; 16:1032-40
  4. Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg 2002; 184:9S-16S
  5. Birmingham CL, Muller JL, Palepu A, et al. The cost of obesity in Canada. CMAJ 1999; 160:483-8
  6. Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg 2007; 17:565-8
  7. Nieben OG, Haboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 1:198-9
  8. Roman S, Napoleon B, Mion F, et al. Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg 2004; 14:539-44
  9. Galloro G, DePalma GD, Catanzano C, et al. Preliminary endoscopic technical report of a new silicone intragastric balloon in the treatment of morbid obesity. Obes Surg 1999; 9:68-71
  10. Totte E, Hendrickk L, Pauwels M, et al. Weight reduction by means of intragastric device: experience with the Bioenterics Intragastric Balloon. Obes Surg 2001; 11:519-23
  11. Sallet JA, Marchesini JB, Paiva DS, et al. Brazillian multicenter study of the intragastric balloon. Obes Surg 2004; 14:991-8
  12. Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: the Italian experience with 2.515 patients. Obes Surg 2005; 15:1161-4
  13. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18: 1611-7
  14. Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg 2008; 18:841-6
  15. Espinet E, Merlo J, Durán R, et al. Tratamiento endoscópico de la obesidad moderada mediante balón intragástrico. II Congreso Nacional de Endoscopia Digestiva. Madrid 2007
  16. García V, Espinet E, Valero M, et al. Importancia de la enfermería en el balón intragástrico endoscópico. XV Jornada Nacional de la AEEED. Murcia 2006
  17. Carbonelli MG, Fusco MA, Cannistra F, et al. Body composition modification in obese patients treated with intragastric balloon. Acta Diabetol 2003; 40(Supl 1):S261-2
  18. Escudero-Sanch>ís A, C